{
  "id": 1585,
  "text": "4</td></tr><tr><td>Cai et al.77,a</td><td>2006</td><td>52</td><td>Cisplatin/ 5 fluorouracil</td><td>84.6</td><td>5-year: 72.7</td><td>5-year: 84.7</td></tr><tr><td>Behtash et al.543</td><td>2006</td><td>22</td><td>Cisplatin/vincristine</td><td>nr </td><td>nr</td><td>5-year: 28</td></tr><tr><td> Termrungruanglert et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 4</td></tr><tr><td>Cai et al.77,a</td><td>2006</td><td>52</td><td>Cisplatin/ 5 fluorouracil</td><td>84.6</td><td>5-year: 72.7</td><td>5-year: 84.7</td></tr><tr><td>Behtash et al.543</td><td>2006</td><td>22</td><td>Cisplatin/vincristine</td><td>nr </td><td>nr</td><td>5-year: 28</td></tr><tr><td> Termrungruanglert et al.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有的化疗方案数据，顺铂联合5-氟尿嘧啶方案显示出了较高的5年生存率优势，达到84.7%。相比之下，顺铂联合长春新碱的方案5年生存率仅为28%，显示出明显的长期生存率差异。这表明顺铂联合5-氟尿嘧啶方案可能在提高宫颈癌患者的长期生存率方面更加有效。",
  "query": "**与不同化疗方案治疗宫颈癌后的5年生存率数据相比，哪种方案显示出了较高的长期生存率优势？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **与不同化疗方案治疗宫颈癌后的5年生存率数据相比，哪种方案显示出了较高的长期生存率优势？**\n\n<reference text>: 4</td></tr><tr><td>Cai et al.77,a</td><td>2006</td><td>52</td><td>Cisplatin/ 5 fluorouracil</td><td>84.6</td><td>5-year: 72.7</td><td>5-year: 84.7</td></tr><tr><td>Behtash et al.543</td><td>2006</td><td>22</td><td>Cisplatin/vincristine</td><td>nr </td><td>nr</td><td>5-year: 28</td></tr><tr><td> Termrungruanglert et al.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有的化疗方案数据，顺铂联合5-氟尿嘧啶方案显示出了较高的5年生存率优势，达到84.7%。相比之下，顺铂联合长春新碱的方案5年生存率仅为28%，显示出明显的长期生存率差异。这表明顺铂联合5-氟尿嘧啶方案可能在提高宫颈癌患者的长期生存率方面更加有效。"
}